Pérez-Neri I, Diéguez-Campa CE

Language: Spanish
References: 18
Page: 50-54
PDF size: 348.18 Kb.

ABSTRACT

Previously it was thought that the presence of citrulline in the central nervous system (CNS) had an exclusively hepatic origin; however, now it is known that there are enzymes in the brain that synthesize it. Although the exact role of this amino acid is unknown, its concentration in cerebrospinal fluid is associated with neurological and psychiatric diseases, so it is suggested that its presence intervenes in the physiology and pathophysiology of the CNS.

REFERENCES

1. 1.Michal G, Schomburg D. Biochemical pathways an atlas of biochemistry and molecular biology. Wiley, Hoboken., 2012.

2. 2.Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001; 64, 365–91.

3. 3.Wink D A, Grisham MB, Mitchell JB, Ford PC. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Meth Enzymol 1996; 268, 12–31.

4. 4.Kuiper MA, Teerlink T, Visser JJ, Bergmans PL, Scheltens P, Wolters EC. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson’s disease, multiple system atrophy, and Alzheimer’s disease patients. J Neural Transm 2000; 107, 183–9.

5. 5.Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 1993; 90, 8103–7.

6. 6.Pérez-Neri I, Castro E, Montes S, Boll MC, Barges-Coll J, Soto-Hernández JL, Ríos C. Arginine, citrulline and nitrate concentrations in the cerebrospinal fluid from patients with acute hydrocephalus. J Chromatogr B 2007;851, 250–6.

7. 7.Pérez-Neri I, Montes S, Boll MC, Ramírez-Bermúdez J, Ríos C. Reply to comment on: “assessment of nitric oxide biosynthesis and peroxynitrite formation within the central nervous system by measuring l-citrulline in the cerebrospinal fluid?” J. Chromatogr B 2005; 819, 345–6.

8. 8.Perez-Neri I, Montes S, Boll M, Ramirezbermudez J, Rios C. Liquid chromatographic–fluorimetric method for the estimation of nitric oxide biosynthesis in the central nervous system. J Chromatogr B 2004; 806,133–9.

9. 9.Maruyama H, Ogawa M, Nishio T, Kobayashi K, Saheki T, Sunohara N. Citrullinemia type II in a 64-year-old man with fluctuating serum citrulline levels. J Neurol Sci 2001; 182, 167–170.

10. 10.Pérez-Neri I, Ramírez-Bermudez J, Flores-Hernandez R, Nente-Chávez, Francisco F, Montes-López S, Soto-Hernandez JL, Ríos-Castañeda C. Disminución de nitritos y nitratos en el líquido cefalorraquídeo de pacientes neurológicos que presentan alucinaciones. Arch Neurocien 2009; 14, 1–2.

11. 11.Pérez-Neri I, Ramírez-Bermudez J, Ramírez-Abascal M, Montes S, Soto-Hernandez JL, Ríos C. La presentación de ideas delirantes asociada con esquizofrenia y encefalitis viral involucra diferentes sistemas de neurotransmisión. Arch Neurocien 2009;14, 24.

12. 12.Molina JA, Jimenez-Jimenez FJ, Gómez P, Vargas C, Navarro JA, Ortı́-Pareja M, Gasalla T, Benito-León J, Bermejo F, Arenas J. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson’s disease. J. Neurol Sci 1997; (150):123–7.

13. 13.Pérez-Neri I, Ramírez-Bermudez J, Montes S, Soto-Hernandez JL, Ramírez-Abascal M, Nente F, Ríos C. Alteraciones en el metabolismo de citrulina y aspartato en pacientes neurológicos y su relevancia para la fisiopatología del delirium. Arch Neurocien 2010;15, 11.

14. 14.Pérez-Neri I, Ojeda-López C, Márquez-Flores MA, Montes S, Ríos C, Ramírez-Bermúdez J, Ramírez-Abascal M, Nente F, Soto-Hernández JL. Alteración en el metabolismo cerebral de aminoácidos en pacientes psiquiátricos y neurológicos con delirium. Arch Neurocien 2011; 16, 18.

15. 15.Pérez-Neri I, Ramírez-Bermudez J, Montes S, Soto-Hernández JL, Ramírez-Abascal M, Nente F, Ríos C. Alteraciones en el metabolismo de citrulina y aspartato en pacientes neurológicos y su relevancia para la fisiopatología del delirium. Arch Neurocien 2011; 16, 19.

16. 16.Reveley MA, De Belleroche J, Recordati A, Hirsch SR. Increased CSF amino acids and ventricular enlargement in schizophrenia: a preliminary study. Biol Psychiatry 1987; 22, 413–20.

17. 17.Pérez-Neri I, Barreto-Malfavón Á, Morales-Ayala J, Flores-Rivera J de J, Ramírez-Bermudez J, Corona T, Ríos C. Marcadores de excitotoxicidad en esclerosis múltiple. Arch Neurocien 2011; 16, 20.

18. 18.Snyder SH, Ferris CD. Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 2000;157, 1738–51.